Skeletal Muscle Quantitative Nuclear Magnetic Resonance Imaging and Spectroscopy as an Outcome Measure for Clinical Trials
Open accessThe DOI matches its Crossref record; 293 of the 293 references it cites were found in a registry or an index.
Abstract
Recent years have seen tremendous progress towards therapy of many previously incurable neuromuscular diseases. This new context has acted as a driving force for the development of novel non-invasive outcome measures. These can be organized in three main categories: functional tools, fluid biomarkers and imagery. In the latest category, nuclear magnetic resonance imaging (NMRI) offers a considerable range of possibilities for the characterization of skeletal muscle composition, function and metabolism. Nowadays, three NMR outcome measures are frequently integrated in clinical research protocols. They are: 1/ the muscle cross sectional area or volume, 2/ the percentage of intramuscular fat and 3/ the muscle water T2, which quantity muscle trophicity, chronic fatty degenerative changes and oedema (or more broadly, “disease activity”), respectively. A fourth biomarker, the contractile tissue volume is easily derived from the first two ones. The fat fraction maps most often acquired with Dixon sequences have proven their capability to detect small changes in muscle composition and have repeatedly shown superior sensitivity over standard functional evaluation. This outcome measure will more than likely be the first of the series to be validated as an endpoint by regulatory agencies. The versatility of contrast generated by NMR has opened many additional possibilities for characterization of the skeletal muscle and will result in the proposal of more NMR biomarkers. Ultra-short TE (UTE) sequences, late gadolinium enhancement and NMR elastography are being investigated as candidates to evaluate skeletal muscle interstitial fibrosis. Many options exist to measure muscle perfusion and oxygenation by NMR. Diffusion NMR as well as texture analysis algorithms could generate complementary information on muscle organization at microscopic and mesoscopic scales, respectively. 31 P NMR spectroscopy is the reference technique to assess muscle energetics non-invasively during and after exercise. In dystrophic muscle, 31 P NMR spectrum at rest is profoundly perturbed, and several resonances inform on cell membrane integrity. Considerable efforts are being directed towards acceleration of image acquisitions using a variety of approaches, from the extraction of fat content and water T2 maps from one single acquisition to partial matrices acquisition schemes. Spectacular decreases in examination time are expected in the near future. They will reinforce the attractiveness of NMR outcome measures and will further facilitate their integration in clinical research trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Precise measurement of muscle72 cell lipid content can be achieved through 1H magnetic resonance spectroscopy (1H MRS).73”
From Imaging of Sarcopenia in Type 2 Diabetes Mellitus (2024) · cites this paper as [72]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Donoho, D. L. (2006) · IEEE Transactions on Information Theory · doi:10.1109/tit.2006.871582 · Cited by 23,994
Donoho, D. L. (2004) · Cited by 16,591
Spin Diffusion Measurements: Spin Echoes in the Presence of a Time-Dependent Field Gradient
Stejskal, E. O., & Tanner, J. E. (1965) · The Journal of Chemical Physics · doi:10.1063/1.1695690 · Cited by 8,286
Brain magnetic resonance imaging with contrast dependent on blood oxygenation.
Ogawa, S., Lee, T. M., Kay, A. R., & Tank, D. W. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.24.9868 · Cited by 6,483
SENSE: Sensitivity encoding for fast MRI
Pruessmann, K. P., Weiger, M., Scheidegger, M. B., & Boesiger, P. (1999) · Magnetic Resonance in Medicine · doi:10.1002/(sici)1522-2594(199911)42:5<952::aid-mrm16>3.0.co;2-s · Cited by 6,251 · cited 1×
“The ability to assess displacement of water protons in vitro and in vivo using diffusion-sensitizing pulsed-field gradients has motivated its use to probe microstructural information beyond the resolution of conventional NMR imaging, i.e. in the range of several microns.”
BackgroundGeneralized autocalibrating partially parallel acquisitions (GRAPPA)
Griswold, M. A., Jakob, P. M., Heidemann, R. M., Nittka, M., Jellus, V., Wang, J., Kiefer, B., & Haase, A. (2002) · Magnetic Resonance in Medicine · doi:10.1002/mrm.10171 · Cited by 5,303 · cited 1×
“The ability to assess displacement of water protons in vitro and in vivo using diffusion-sensitizing pulsed-field gradients has motivated its use to probe microstructural information beyond the resolution of conventional NMR imaging, i.e. in the range of several microns.”
BackgroundCellular and molecular mechanisms of fibrosis
Wynn, T. (2008) · The Journal of Pathology · doi:10.1002/path.2277 · Cited by 4,495
Tofts, P. S., Brix, G., Buckley, D. L., Evelhoch, J. L., Henderson, E., Knopp, M. V., Larsson, H. B. W., Lee, T.-Y., Mayr, N. A., Parker, G. J. M., et al. (1999) · Journal of Magnetic Resonance Imaging · doi:10.1002/(sici)1522-2586(199909)10:3<223::aid-jmri2>3.0.co;2-s · Cited by 3,143
Lustig, M., Donoho, D. L., Santos, J. M., & Pauly, J. M. (2008) · IEEE Signal Processing Magazine · doi:10.1109/msp.2007.914728 · Cited by 2,246 · cited 1×
“The ability to assess displacement of water protons in vitro and in vivo using diffusion-sensitizing pulsed-field gradients has motivated its use to probe microstructural information beyond the resolution of conventional NMR imaging, i.e. in the range of several microns.”
BackgroundStrimbu, K., & Tavel, J. A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833ed177 · Cited by 2,062 · cited 1×
“∗Correspondence to: P.G. Carlier, Institut de Myologie and CEA, DSV, I2BM, MIRCen, Laboratoire de RMN, Pitie- Salpetriere University Hospital, Bd de l’Hôpital, 75651 Paris Cedex 13, France.”
Background
Research works printed but not linked: 2
- Rooney WD, Pollaro JR, Forbes SC, et al Application of the Extended Phas e Graph Technique to Improve T2 Quantitation Across Sites. 2011 In: Proceedings ISMRM 5419.
- Wary C, Azzabou N, Giraudeau C, et al Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy. NMR Biomed. 2015 b; 28: 1150– 62. 26215733 · DOI
Cited by
MR biomarkers predict clinical function in Duchenne muscular dystrophy
Barnard, A. M., Willcocks, R. J., Triplett, W. T., Forbes, S. C., Daniels, M. J., Chakraborty, S., Lott, D. J., Senesac, C., Finanger, E. L., Harrington, A. T., et al. (2020) · Neurology · doi:10.1212/wnl.0000000000009012 · Cited by 99
“Skeletal muscle MRI and magnetic resonance (MR) spectroscopy (MRS) measures are noninvasive biomarkers that are sensitive to pathologic changes in dystrophic muscles, and MR biomarkers have the potential to serve as clinical trial endpoints.(6,7) Muscle MRI transverse magnetization relaxation time constant (T2) is alt…”
BackgroundMRI in Neuromuscular Diseases: An Emerging Diagnostic Tool and Biomarker for Prognosis and Efficacy
Dahlqvist, J. R., Widholm, P., Leinhard, O. D., & Vissing, J. (2020) · Annals of Neurology · doi:10.1002/ana.25804 · Cited by 90
“In primary inflammatory myopathies, it can act as an indicator of disease activity.(6) STIR sequences cannot quantify level of edema.”
BackgroundMethodSchlaffke, L., Rehmann, R., Rohm, M., Otto, L. A. M., Luca, A. D., Burakiewicz, J., Baligand, C., Monte, J. R., den Harder, C., Hooijmans, M. T., et al. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4119 · Cited by 90
“Therefore, changing from a standing to a lying position could cause a signal drop in the T2 time due to a change in muscle activity, which should, however, be a process lasting several minutes rather than one hour.(32) The decrease in water‐T2 time could also be a consequence of altered intramuscular perfusion resulti…”
BackgroundEngelke, K., Chaudry, O., Gast, L. V., Eldib, M., Wang, L., Larédo, J.-D., Schett, G. A., & Nagel, A. M. (2023) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2023.07.005 · Cited by 109
MR Imaging of Atraumatic Muscle Disorders
Smitaman, E. E., Flores, D. V., Gómez, C. M., & Pathria, M. N. (2018) · Radiographics · doi:10.1148/rg.2017170112 · Cited by 82
MYO-MRI diagnostic protocols in genetic myopathies
Warman‐Chardon, J., Díaz‐Manera, J., Tasca, G. A., Bönnemann, C. G., Gómez‐Andrés, D., Heerschap, A., Mercuri, E. M., Francesco Muntoni, A., Pichiecchio, A., Ricci, E., et al. (2019) · Neuromuscular Disorders · doi:10.1016/j.nmd.2019.08.011 · Cited by 74
Strijkers, G. J., Araújo, E. C. D. A., Azzabou, N., Bendahan, D., Blamire, A. M., Burakiewicz, J., Carlier, P. G., Damon, B. M., Deligianni, X., Froeling, M., et al. (2018) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-180333 · Cited by 76
“PDE is often assigned to membrane breakdown products and its signal may be used as a biomarker for treatments [6].”
BackgroundSelf-citationZullo, A., Fleckenstein, J., Schleip, R., Hoppe, K., Wearing, S. C., & Klingler, W. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00592 · Cited by 82
“, 2018) or MRI signal intensity can be used to evaluate the composition of the skeletal muscle (Carlier et al., 2016).”
BackgroundHénin, G., Loumaye, A., Leclercq, I. A., & Lanthier, N. (2023) · JHEP Reports · doi:10.1016/j.jhepr.2023.100963 · Cited by 86
“42,43 Furthermore, proton magnetic resonance spectroscopy (MRS) enables measurement of the IMLC and the extramyocellular lipid content (EMLC) based on their differences in resonant frequencies after excitation of hydrogen nuclei.”
BackgroundEuropean muscle MRI study in limb girdle muscular dystrophy type R1/2A (LGMDR1/LGMD2A)
Barp, A., Laforêt, P., Bello, L., Tasca, G. A., Vissing, J., Monforte, M., Ricci, E., Choumert, A., Stojkovic, T., Malfatti, E., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09539-y · Cited by 64
Self-citationRecent technical developments and clinical research applications of sodium (23Na) MRI
Gast, L. V., Platt, T., Nagel, A. M., & Gerhalter, T. (2023) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2023.04.002 · Cited by 70
Monitoring clinical progression with mitochondrial disease biomarkers
Steele, H. E., Horváth, R., Lyon, J. J., & Chinnery, P. F. (2017) · Brain · doi:10.1093/brain/awx168 · Cited by 70
“The main focus is on the measurement of muscle volume, and the relative amount of intramuscular fat and water (reviewed in Carlier et al., 2016).”
BackgroundGerhalter, T., Gast, L. V., Marty, B., Martin, J., Trollmann, R., Schüssler, S. C., Roemer, F. W., Laun, F. B., Uder, M., Schröder, R., et al. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26681 · Cited by 70
Self-citationDahlqvist, J. R., Andersen, G., Khawajazada, T., Vissing, C. R., Thomsen, C. E., & Vissing, J. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09242-y · Cited by 59
Kim, H. K., Serai, S. D., Lindquist, D. M., Merrow, A. C., Horn, P. S., Kim, D. H., & Wong, B. L. Y. (2015) · American Journal of Roentgenology · doi:10.2214/ajr.14.13755 · Cited by 64
Paoletti, M., Pichiecchio, A., Piccinelli, S. C., Tasca, G. A., Berardinelli, A. L., Padovani, A., & Filosto, M. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00078 · Cited by 59
“A large voxel would, in fact, delete subtle differences and make the image too homogeneous with consequent loss of information, a small voxel would be largely influenced by rumor with possible confounding effect on the texture (29).”
BackgroundInfluentialMRI biomarkers of proximal nerve injury in CIDP
Lichtenstein, T., Sprenger, A., Weiss, K., Slebocki, K., Cervantes, B., Karampinos, D. C., Maintz, D. C., Fink, G. R., Henning, T. D., & Lehmann, H. C. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.502 · Cited by 54
Overview of MR Image Segmentation Strategies in Neuromuscular Disorders
Ogier, A. C. C., Hostin, M., Bellemare, M., & Bendahan, D. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.625308 · Cited by 59
“As a result, quantitative analyses have been mainly performed over a limited number of slices and not on the whole 3D datasets (4, 10) or on a limited number of individual muscles (6).”
BackgroundLongitudinal study of MRI and functional outcome measures in facioscapulohumeral muscular dystrophy
Wang, L. H., Shaw, D., Faino, A., Budech, C. B., Lewis, L., Statland, J. M., Eichinger, K. J., Tapscott, S. J., Tawil, R., & Friedman, S. D. (2021) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-021-04134-7 · Cited by 52
“While some hybrid (imaging+MRS) approach could certainly be used, given some biopsy samples from normal T1/STIR appearing tissue can show histologic abnormalities [10] or be energetically compromised [19], there remains more work to be done to determine if other biomarkers might provide additional explanatory variance…”
BackgroundLower extremity muscle pathology in myotonic dystrophy type 1 assessed by quantitative MRI
Heskamp, L., van Nimwegen, M., Ploegmakers, M. J. M., Bassez, G., Deux, J., Cumming, S. A., Monckton, D. G., van Engelen, B. G. M., & Heerschap, A. (2019) · Neurology · doi:10.1212/wnl.0000000000007648 · Cited by 52
“Increased T2water indicates edema caused by inflammation, necrosis, or swelling of myocytes, although, as in other muscular dystrophies, it remains unknown what the precise origins are for the observed increases in all cases.(6)”
BackgroundInfluentialLongitudinal characterization of biomarkers for spinal muscular atrophy
Bonati, U., Holiga, Š., Hellbach, N., Risterucci, C., Bergauer, T., Tang, W., Hafner, P., Thoeni, A., Bieri, O., Gerlach, I., et al. (2017) · Annals of Clinical and Translational Neurology · doi:10.1002/acn3.406 · Cited by 50
Muscle MRI and functional outcome measures in Becker muscular dystrophy
Barp, A., Bello, L., Caumo, L., Campadello, P., Semplicini, C., Lazzarotto, A., Sorarú, G., Calore, C., Rampado, A., Motta, R., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16170-2 · Cited by 49
Quantification of disease progression in spinal muscular atrophy with muscle MRI—a pilot study
Otto, L. A. M., Froeling, M., van Eijk, R. P. A., Asselman, F., Wadman, R. I., Cuppen, I., Hendrikse, J., & van der Pol, W. L. (2021) · NMR in Biomedicine · doi:10.1002/nbm.4473 · Cited by 48
Monitoring skeletal muscle chronic fatty degenerations with fast T1-mapping
Marty, B., Coppa, B., & Carlier, P. G. (2018) · European Radiology · doi:10.1007/s00330-018-5433-z · Cited by 46
“imaging (MRI)-based outcome measures for monitoring disease progression or therapeutic interventions [1, 2].”
Self-citationMuscle imaging in myositis: MRI, US, and PET
Albayda, J., Demonceau, G., & Carlier, P. G. (2022) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2022.101765 · Cited by 47
Self-citationMR fingerprinting for water T1 and fat fraction quantification in fat infiltrated skeletal muscles
Marty, B., & Carlier, P. G. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.27960 · Cited by 48
Self-citationDeep learning for automatic segmentation of thigh and leg muscles
Agosti, A., Shaqiri, E., Paoletti, M., Solazzo, F., Bergsland, N., Colelli, G., Savini, G., Muzic, S. I., Santini, F., Deligianni, X., et al. (2021) · Magnetic Resonance Materials in Physics Biology and Medicine · doi:10.1007/s10334-021-00967-4 · Cited by 58
Nuñez‐Peralta, C., Alonso‐Pérez, J., Llauger, J., Segovia, S., Montesinos, P., Belmonte, I., Pedrosa, I., Montiel, E., Alonso‐Jiménez, A., Sánchez‐Gonzalez, J., et al. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12555 · Cited by 43
“Quantification of FF using Dixon analysis can be a complicated task that requires a high degree of specialization.(31) Ta b le 9 In cr ea se in fa t fr ac ti o n d ep en d in g o n vi si t 0 m ea n th ig h fa t fr ac ti o n”
MethodKeene, K. R., Beenakker, J. M., Hooijmans, M. T., Naarding, K. J., Niks, E. H., Otto, L. A. M., van der Pol, W. L., Tannemaat, M. R., Kan, H. E., & Froeling, M. (2020) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28290 · Cited by 43
Evaluation of inflammatory lesions over 2 years in facioscapulohumeral muscular dystrophy
Dahlqvist, J. R., Poulsen, N. S., Østergaard, S., Fornander, F., Borch, J. D. S., Danielsen, E. R., Thomsen, C. E., & Vissing, J. (2020) · Neurology · doi:10.1212/wnl.0000000000010155 · Cited by 43
Marty, B., & Carlier, P. G. (2019) · Scientific Reports · doi:10.1038/s41598-019-43398-x · Cited by 45
Self-citationForbes, S. C., Arora, H., Willcocks, R. J., Triplett, W. T., Rooney, W. D., Barnard, A. M., Alabasi, U. M., Wang, D.-J., Lott, D. J., Senesac, C., et al. (2020) · Radiology · doi:10.1148/radiol.2020192210 · Cited by 42
“S muscle markers of disease involvement in Duchenne muscular dystrophy (DMD) by using MRI and proton (1H) MR spectroscopy are increasingly considered to be end points to evaluate potential therapeutic interventions in clinical trials (1,2).”
MethodLassche, S., Küsters, B., Heerschap, A., Schyns, M. V. P., Ottenheijm, C. A. C., Voermans, N. C., & van Engelen, B. G. M. (2020) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-200543 · Cited by 41
“TIRM hyperintensity is considered to reflect muscle edema indicative of muscle inflammation and regeneration [21].”
BackgroundSkeletal muscle magnetic resonance imaging in Pompe disease
Díaz‐Manera, J., Walter, G., & Straub, V. W. (2020) · Muscle & Nerve · doi:10.1002/mus.27099 · Cited by 46
“Interestingly, PDEs are increased earlier in the disease process and therefore they are considered a good marker of acute muscle damage.(25) (31)P spectroscopy has also been used to study muscle metabolism in glycogenoses, such as McArdle disease, showing decreased resting values of PCr / (PCr + Pi) and increased pH l…”
BackgroundInfluentialCompositional and Functional MRI of Skeletal Muscle: A Review
Hooijmans, M. T., Schlaffke, L., Bolsterlee, B., Schlaeger, S., Marty, B., & Mazzoli, V. (2023) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.29091 · Cited by 49
Self-citationReyngoudt, H., Marty, B., Boisserie, J., Louër, J. L., Koumako, C., Baudin, P., Wong, B. L. Y., Stojkovic, T., Béhin, A., Gidaro, T., et al. (2020) · European Radiology · doi:10.1007/s00330-020-07487-0 · Cited by 38
“In recent years, fatwater-separation-based MRI has been designated as a validated, objective, quantitative outcome measure that is sensitive to change [1].”
BackgroundSelf-citationOgier, A. C. C., Heskamp, L., Michel, C. P., Fouré, A., Bellemare, M., Troter, A. L., Heerschap, A., & Bendahan, D. (2019) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28030 · Cited by 36
Keene, K. R., van Vught, L., van de Velde, N. M., Ciggaar, I. A., Notting, I. C., Genders, S. W., Verschuuren, J. J. G. M., Tannemaat, M. R., Kan, H. E., & Beenakker, J. M. (2020) · NMR in Biomedicine · doi:10.1002/nbm.4407 · Cited by 39
Reyngoudt, H., Smith, F. E., Araújo, E. C. D. A., Wilson, I., Fernández‐Torrón, R., James, M. K., Moore, U., Díaz‐Manera, J., Marty, B., Azzabou, N., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12987 · Cited by 36
“Skeletal muscle water T2 is another quantitative MRI outcome measure, one that is non-specific, yet sensitive to mechanisms such as inflammation and oedema, and reflects the disease activity.(11) Water T2 was, in general, significantly elevated in patients, and the highest values were found in the anterior parts of th…”
BackgroundSelf-citationImaging respiratory muscle quality and function in Duchenne muscular dystrophy
Barnard, A. M., Lott, D. J., Batra, A., Triplett, W. T., Forbes, S. C., Riehl, S. L., Willcocks, R. J., Smith, B. K., Vandenborne, K., & Walter, G. A. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09481-z · Cited by 40
Mankodi, A. K., Azzabou, N., Bulea, T. C., Reyngoudt, H., Shimellis, H., Ren, Y., Kim, E., Fischbeck, K. H., & Carlier, P. G. (2017) · Neuromuscular Disorders · doi:10.1016/j.nmd.2017.04.008 · Cited by 39
“A potential limitation of the 2 point Dixon method is that swaps between fat and water components can occur between limbs or inside limb segments [28].”
MethodSelf-citationDiffusion tensor imaging reveals changes in non‐fat infiltrated muscles in late onset Pompe disease
Rehmann, R., Froeling, M., Rohm, M., Forsting, J., Kley, R. A., Schmidt‐Wilcke, T., Karabul, N., Meyer‐Frießem, C. H., Vollert, J., Tegenthoff, M., et al. (2020) · Muscle & Nerve · doi:10.1002/mus.27021 · Cited by 40
Kolkovsky, A. L. L., Carlier, P. G., Marty, B., & Meyerspeer, M. (2022) · NMR in Biomedicine · doi:10.1002/nbm.4735 · Cited by 34
Self-citationMartel‐Duguech, L., Alonso‐Jiménez, A., Bascuñana, H., Díaz‐Manera, J., Llauger, J., Nuñez‐Peralta, C., Biagetti, B., Montesinos, P., Webb, S. M., & Valassi, E. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgz329 · Cited by 36
Santini, F., Deligianni, X., Paoletti, M., Solazzo, F., Weigel, M., de Sousa, P. L., Bieri, O., Monforte, M., Ricci, E., Tasca, G. A., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.630387 · Cited by 30
“The effect would only be seen in the different T2 values of the fat components; therefore, this functionality is not currently implemented, in line with existing spin-echo-based methods for muscle imaging (14, 15, 17, 23).”
MethodResultMarty, B., Reyngoudt, H., Boisserie, J., Louër, J. L., Araújo, E. C. D. A., Fromes, Y., & Carlier, P. G. (2021) · Radiology · doi:10.1148/radiol.2021204028 · Cited by 33
Self-citationMartins-Bach, A. B., Bachasson, D., Araújo, E. C. D. A., Soustelle, L., de Sousa, P. L., Fromes, Y., & Carlier, P. G. (2021) · Scientific Reports · doi:10.1038/s41598-020-78747-8 · Cited by 34
Self-citationQuantitative Muscle-MRI Correlates with Histopathology in Skeletal Muscle Biopsies
Güttsches, A., Rehmann, R., Schreiner, A., Rohm, M., Forsting, J., Froeling, M., Tegenthoff, M., Vorgerd, M., & Schlaffke, L. (2021) · Journal of Neuromuscular Diseases · doi:10.3233/jnd-210641 · Cited by 33
“The correlation of water-T2 with histopathologic parameters like CD68 or the amount of vacuoles can thus be regarded as a marker for the activity of the disease, as had already been postulated by Carlier et al. in inflammatory myopathies [35].”
Spatially regularized parametric map reconstruction for fast magnetic resonance fingerprinting
Balsiger, F., Jungo, A., Scheidegger, O., Carlier, P. G., Reyes, M., & Marty, B. (2020) · Medical Image Analysis · doi:10.1016/j.media.2020.101741 · Cited by 28
Self-citationNuñez‐Peralta, C., Alonso‐Pérez, J., & Díaz‐Manera, J. (2020) · Current Opinion in Neurology · doi:10.1097/wco.0000000000000851 · Cited by 29
“water content is typically visualized using shorttau inversion recovery sequences (STIR), which has the advantage of producing a T2-weighted image with suppression of lipid signals [22].”
BackgroundDecreased water T2 in fatty infiltrated skeletal muscles of patients with neuromuscular diseases
Schlaeger, S., Weidlich, D., Klupp, E., Montagnese, F., Deschauer, M., Schoser, B. G. H., Bublitz, S. K., Ruschke, S., Zimmer, C., Rummeny, E. J., et al. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4111 · Cited by 26
“First, elevated T2w is currently considered as a marker for a pathological process of muscle fibers themselves not being affected by surrounding fatty infiltration.(9) However, the present results indicate that T2w shows at least a mild dependence on the degree of the fatty infiltration, and this should be taken into…”
BackgroundLiu, M., Zhang, X., Fan, W., He, S., Wang, Y., & Chen, Z. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000658 · Cited by 26
“5 muscle([19]) based on IVIM MRI, muscle blood flow and oxygenation based on nuclear MRI (NMRI) and spectroscopy,([32]) the muscle energetics based on the 31P NMRI,([33]) and the measurement of minimal fat in normal skeletal muscles based on T2 relaxation time mapping (T2 maps) and MR spectroscopy.”
MethodReyngoudt, H., Kolkovsky, A. L. L., & Carlier, P. G. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4115 · Cited by 26
Self-citationMonforte, M., Attarian, S., Vissing, J., Díaz‐Manera, J., Tasca, G. A., Attarian, S., Badiani, R., Bendahan, D., Carlier, P. G., Carlier, R., et al. (2022) · Neuromuscular Disorders · doi:10.1016/j.nmd.2022.10.005 · Cited by 25
Self-citationBakermans, A. J., Wessel, C. H., Zheng, K. H., Groot, P. F. C., Stroes, E. S. G., & Nederveen, A. J. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.26841 · Cited by 30
“Noninvasive magnetic resonance (MR) methods can provide such indices.(6,7) Phosphorus-31 MR spectroscopy ((31)P-MRS) has been widely used to study in vivo muscle high-energy phosphate metabolism through the direct detection of phosphocreatine (PCr), adenosine 50-triphosphate (ATP), and inorganic phosphate (Pi).”
BackgroundNelissen, J. L., de Graaf, L., Traa, W. A., Schreurs, T. J. L., Moerman, K. M., Nederveen, A. J., Sinkus, R., Oomens, C. W. J., Nicolay, K., & Strijkers, G. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169864 · Cited by 31
Simultaneous T1, T2, and T1ρ relaxation mapping of the lower leg muscle with MR fingerprinting
Sharafi, A., Medina, K., Zibetti, M. V. W., Rao, S., Cloos, M. A., Brown, R., & Regatte, R. R. (2021) · Magnetic Resonance in Medicine · doi:10.1002/mrm.28704 · Cited by 25
Heskamp, L., Ogier, A. C. C., Bendahan, D., & Heerschap, A. (2022) · Communications Medicine · doi:10.1038/s43856-022-00217-1 · Cited by 27
“MRI is an ideal tool for the investigation of these pathological processes as it can quantitatively assess the relative amount of fat in skeletal muscle tissue 12 .”
Assessment of Extracellular Volume Fraction in Becker Muscular Dystrophy by Using MR Fingerprinting
Marty, B., Baudin, P., Araújo, E. C. D. A., Fromes, Y., Wahbi, K., & Reyngoudt, H. (2023) · Radiology · doi:10.1148/radiol.221115 · Cited by 23
Self-citationQuantitative 1H and 23Na muscle MRI in Facioscapulohumeral muscular dystrophy patients
Gerhalter, T., Marty, B., Gast, L. V., Porzelt, K., Heiss, R., Uder, M., Schwab, S., Carlier, P. G., Nagel, A. M., & Türk, M. (2020) · Journal of Neurology · doi:10.1007/s00415-020-10254-2 · Cited by 25
Self-citationHeskamp, L., Okkersen, K., van Nimwegen, M., Ploegmakers, M. J. M., Bassez, G., Deux, J., van Engelen, B. G. M., & Heerschap, A. (2020) · Radiology · doi:10.1148/radiol.2020192518 · Cited by 24
Intramuscular fatty infiltration and physical function in controlled acromegaly
Martel‐Duguech, L., Alonso‐Pérez, J., Bascuñana, H., Díaz‐Manera, J., Llauger, J., Nuñez‐Peralta, C., Montesinos, P., Webb, S. M., & Valassi, E. (2021) · European Journal of Endocrinology · doi:10.1530/eje-21-0209 · Cited by 22
Schlaeger, S., Sollmann, N., Zoffl, A., Becherucci, E. A., Weidlich, D., Kottmaier, E., Riederer, I., Greve, T., Montagnese, F., Deschauer, M., et al. (2021) · Diagnostics · doi:10.3390/diagnostics11061056 · Cited by 22
“Recent progress in genetic diagnostics provides new insights into the underlying pathogenesis [4,5].”
BackgroundUpdate on muscle imaging in myositis
Tan, A. L., Matteo, A. D., Wakefield, R. J., & Biglands, J. D. (2023) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000975 · Cited by 28
“MRI measurements of intramuscular fat fraction are often used as biomarkers of disease progression and are commonly used as outcome measures in clinical studies [20].”
MethodThe Role of Imaging Biomarkers in the Assessment of Sarcopenia
Sanz‐Requena, R., Martínez‐Arnau, F. M., Pablos, A., Flor-Rufino, C., Barrachina-Igual, J., García‐Martí, G., Martí‐Bonmatí, L., & Pérez‐Ros, P. (2020) · Diagnostics · doi:10.3390/diagnostics10080534 · Cited by 25
“, percentiles) or on texture and heterogeneity properties of the images, which have been proposed already to detect structural differences in the muscle, fat and bone marrow [13,65,66].”
BackgroundInfluentialMuscle MRI in two SMA patients on nusinersen treatment: A two years follow-up
Barp, A., Carraro, E., Albamonte, E., Salmin, F., Lunetta, C., Comi, G. P., Messina, C., Albano, D., Chianca, V., Sconfienza, L. M., et al. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.117067 · Cited by 22
Diagnosis and Management of Sarcopenia after Hip Fracture Surgery: Current Concept Review
Yoo, J., Kim, J.-T., Park, C. H., & Cha, Y. (2022) · Hip & Pelvis · doi:10.5371/hp.2022.34.1.1 · Cited by 24
de Visser, M., Carlier, P. G., Vencovský, J., Kubínová, K., Preuße, C., Albayda, J., Allenbach, Y., Benvéniste, O., Carlier, P. G., Diederichsen, L. P., et al. (2023) · Neuromuscular Disorders · doi:10.1016/j.nmd.2023.08.014 · Cited by 23
Self-citationAn advanced magnetic resonance imaging perspective on the etiology of deep tissue injury
Nelissen, J. L., Traa, W. A., de Boer, H. H., de Graaf, L., Mazzoli, V., Savci-Heijink, C. D., Nicolay, K., Froeling, M., Bader, D. L., Nederveen, A. J., et al. (2018) · Journal of Applied Physiology · doi:10.1152/japplphysiol.00891.2017 · Cited by 21
“This strategy has been increasingly adopted in MRI to improve the overall diagnostic power (1, 16, 18, 32, 35, 41, 47, 53, 57, 64, 65, 72, 81, 90, 100, 109).”
Cysteamine-induced depletion of somatostatin and prolactin.
Wj, M., Sm, S., & Jb, M. (1985) · PubMed · Cited by 23
Warman‐Chardon, J., Díaz‐Manera, J., Tasca, G. A., & Straub, V. W. (2020) · Neuromuscular Disorders · doi:10.1016/j.nmd.2020.08.360 · Cited by 20
Water T2 could predict functional decline in patients with dysferlinopathy
Moore, U., Araújo, E. C. D. A., Reyngoudt, H., Gordish‐Dressman, H., Smith, F. E., Wilson, I., James, M. K., Mayhew, A. G., Rufibach, L., Day, J., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13063 · Cited by 20
“Although these sequences have been demonstrated to be useful for the diagnosis of patients with neuromuscular diseases, their interpretation can be biased and they lack reproducibility, which hampers their application in longitudinal follow-up studies designed over short periods of time.(15) In contrast, quantitative…”
BackgroundMethodSelf-citationQuantitative muscle MRI captures early muscle degeneration in calpainopathy
Forsting, J., Rohm, M., Froeling, M., Güttsches, A., Südkamp, N., Roos, A., Vorgerd, M., Schlaffke, L., & Rehmann, R. (2022) · Scientific Reports · doi:10.1038/s41598-022-23972-6 · Cited by 25
James, G., Ahern, B. J., Goodwin, W., Goss, B. G. S., & Hodges, P. W. (2024) · European Spine Journal · doi:10.1007/s00586-024-08234-5 · Cited by 24
“Investigation of the nature of fibrotic alterations to the multifidus are less clear, because of difficulties imaging connective tissue [20].”
Schlaeger, S., Weidlich, D., Klupp, E., Montagnese, F., Deschauer, M., Schoser, B. G. H., Bublitz, S. K., Ruschke, S., Zimmer, C., Rummeny, E. J., et al. (2019) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27032 · Cited by 20
“To the best of the authors’ knowledge, the present work is the first to compare quantitative spatially-resolved imaging data based on T2 maps with MRS in a large number of patients with NMD. Robust T2w mapping, which is comparable to MRS as a reference standard, is essential to get an insight into the spatial distribu…”
BackgroundMethodInfluentialMagnetic resonance elastography of skeletal muscle deep tissue injury
Nelissen, J. L., Sinkus, R., Nicolay, K., Nederveen, A. J., Oomens, C. W. J., & Strijkers, G. J. (2019) · NMR in Biomedicine · doi:10.1002/nbm.4087 · Cited by 19
Gidaro, T., Reyngoudt, H., Louër, J. L., Béhin, A., Toumi, F., Villeret, M., Araújo, E. C. D. A., Baudin, P., Marty, B., Annoussamy, M., et al. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09569-6 · Cited by 18
Self-citationNoehren, B. W., Hardy, P., Andersen, A. H., Brightwell, C. R., Fry, J. L., Vandsburger, M. H., Thompson, K. L., & Fry, C. S. (2021) · The Journal of Physiology · doi:10.1113/jp281964 · Cited by 18
“One alternative is to utilize gadolinium-based contrast agents that accumulate in the extracellular volume between ECM and muscle, and create T1-weighted contrast in proportion to water volume (Carlier et al. 2016).”
Backgroundvan den Noort, J. C., van der Leeden, M., Stapper, G., Wirth, W., Maas, M. M., Roorda, L. D., Lems, W. F., Dekker, J., & van der Esch, M. (2022) · BMC Musculoskeletal Disorders · doi:10.1186/s12891-022-05025-1 · Cited by 24
Locher, N., Wagner, B., Balsiger, F., & Scheidegger, O. (2022) · European Radiology · doi:10.1007/s00330-022-08862-9 · Cited by 17
“relaxometry has a role in the diagnostic workup of NMDs in detecting early abnormalities beyond its current use as an outcome measure [5, 7].”
BackgroundMethodSelf-citationReyngoudt, H., Marty, B., Araújo, E. C. D. A., Baudin, P., Louër, J. L., Boisserie, J., Béhin, A., Servais, L., Gidaro, T., & Carlier, P. G. (2020) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-20-39 · Cited by 17
“Currently, quantitative NMRI is being used more and more in the evaluation of the disease of neuromuscular disorders (10) such as Duchenne muscular dystrophy (DMD) (11-13), Becker muscular dystrophy (BMD) (14), facioscapulohumeral muscular dystrophy (FSHD) (15), limb-girdle muscular dystrophy type 2I (16), late-onset…”
BackgroundMethodSelf-citationSavini, G., Asteggiano, C., Paoletti, M., Parravicini, S., Pezzotti, E., Solazzo, F., Muzic, S. I., Santini, F., Deligianni, X., Gardani, A., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.613834 · Cited by 17
“By contrast, high w-T2 signal has been proposed in neuromuscular disorder studies as a potential marker of disease activity, though non-specific, mostly reflecting initial stages of the disease (15).”
BackgroundBanse, H. E., Whitehead, A. E., McFarlane, D., & Chelikani, P. K. (2021) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2021.106620 · Cited by 19
Vincenten, S. C. C., Teeselink, S., Mul, K., Heskamp, L., Kan, H. E., Heerschap, A., Cameron, D., Tasca, G. A., Leung, D. G., Voermans, N. C., et al. (2025) · Neuromuscular Disorders · doi:10.1016/j.nmd.2025.105274 · Cited by 15
“T2 water relaxation time is preferred because it is a quantitative measurement, but to use it appropriately one needs to take into account known influencing factors, such as physical exercise [111] and fat fraction [110,112], which influences overall T2 relaxation time.”
Reyngoudt, H., Baudin, P., Araújo, E. C. D. A., Bachasson, D., Boisserie, J., Mariampillai, K., Annoussamy, M., Allenbach, Y., Hogrel, J., Carlier, P. G., et al. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13451 · Cited by 15
“Several 31 controls, including elevated P i,tot /PCr and PDE/ γ ATP in triceps surae ( P 0.001), increased PME/ γ ATP in triceps surae and quadriceps ( P < 0.001), and increased pH w in quadriceps ( P = 0.002).”
BackgroundInfluentialSelf-citationPorcari, P., Hall, M. G., Clark, C. A., Greally, E., Straub, V. W., & Blamire, A. M. (2020) · NMR in Biomedicine · doi:10.1002/nbm.4276 · Cited by 16
A quantitative method to assess muscle edema using short TI inversion recovery MRI
Dahlqvist, J. R., Salim, R., Thomsen, C. E., & Vissing, J. (2020) · Scientific Reports · doi:10.1038/s41598-020-64287-8 · Cited by 15
Myostatin and follistatin as monitoring and prognostic biomarkers in dysferlinopathy
Moore, U., Fernández‐Simón, E., Schiava, M., Cox, D., Gordish‐Dressman, H., James, M. K., Mayhew, A. G., Wilson, I., Guglieri, M., Rufibach, L., et al. (2023) · Neuromuscular Disorders · doi:10.1016/j.nmd.2023.01.001 · Cited by 14
Self-citationVincenten, S. C. C., Voermans, N. C., Cameron, D., van Engelen, B. G. M., van Alfen, N., & Mul, K. (2024) · Clinical Neurophysiology · doi:10.1016/j.clinph.2024.02.036 · Cited by 13
Recent Advances in Pediatric Brain, Spine, and Neuromuscular Magnetic Resonance Imaging Techniques
Krishnamurthy, R., Wang, D. J. J., Cervantes, B., McAllister, A. S., Nelson, E. E., Karampinos, D. C., & Hu, P. (2019) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2019.03.001 · Cited by 13
The expanding role of MRI in neuromuscular disorders
Carlier, P. G., & Reyngoudt, H. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0346-2 · Cited by 13
Self-citationEmerging and established biomarkers of oculopharyngeal muscular dystrophy
Smith, I. C. P., Chakraborty, S., Bourque, P. R., Sampaio, M. L., Melkus, G., Lochmüller, H., Woulfe, J., Parks, R. J., Brais, B., & Warman‐Chardon, J. (2023) · Neuromuscular Disorders · doi:10.1016/j.nmd.2023.09.010 · Cited by 14
Imaging of Sarcopenia in Type 2 Diabetes Mellitus
Wang, D., Zhang, G., Yu, Y., & Zhang, Z. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s443572 · Cited by 11
Rehmann, R., Enax‐Krumova, E., Meyer‐Frießem, C. H., & Schlaffke, L. (2023) · BMC Medical Imaging · doi:10.1186/s12880-023-00995-7 · Cited by 11
“An elevated FF, as observed in our cohort, relates to chronic muscle degeneration and shows higher sensitivity compared to MRC testing and qualitative MRI in terms of capturing muscle degeneration in myopathies [26, 47].”
BackgroundEvaluation of Neuromuscular Diseases and Complaints by Quantitative Muscle MRI
Schlaffke, L., Rehmann, R., Güttsches, A., Vorgerd, M., Meyer‐Frießem, C. H., Dinse, H. R., Enax‐Krumova, E., Froeling, M., & Forsting, J. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13071958 · Cited by 14
Krkoška, P., Kokošová, V., Dostál, M., Vlažná, D., Keřkovský, M., Straka, M., Gerstberger, R., Matulová, K., Ovesná, P., & Adamová, B. (2024) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-23-1796 · Cited by 16
“Another biomarker, functional muscle volume (FMV), is easily derived from two biomarkers described above (TMV and FF) and is a preferred parameter over TMV (7).”
Quantitative Skeletal Muscle Imaging Using 3D MR Fingerprinting With Water and Fat Separation
Marty, B., Kolkovsky, A. L. L., Araújo, E. C. D. A., & Reyngoudt, H. (2020) · Journal of Magnetic Resonance Imaging · doi:10.1002/jmri.27381 · Cited by 14
“Moreover, unlike techniques based on lipid suppression, our MRF sequence simultaneously derives FF maps, which is now a largely accepted biomarker of disease severity in numerous NMDs.(1) Limitations This study was performed at a single center and on a small number of subjects.”
MethodSelf-citationWeidensteiner, C., Madoerin, P., Deligianni, X., Haas, T., Bieri, O., D’Antonoli, T. A., Bracht-Schweizer, K., Romkes, J., Pieri, E. D., Santini, F., et al. (2021) · Frontiers in Neurology · doi:10.3389/fneur.2021.630435 · Cited by 11
“However, residual fat signal from an imperfect fat suppression may influence the measured T2 values (26).”
BackgroundMastropietro, A., Peruzzo, D., Taccogna, M. G., Sanna, N., Casali, N., Nossa, R., Biffi, E., Ambrosini, E., Pedrocchi, A., & Rizzo, G. (2025) · JMIR Rehabilitation and Assistive Technologies · doi:10.2196/64825 · Cited by 12
“Diffusion MRI has been widely used to assess the diffusivity of water molecules in tissue and the use of DTI was proposed to indirectly infer microstructural changes of muscle tissue [48,49].”
Paoletti, M., Monforte, M., Barzaghi, L., Tasca, G. A., Bergsland, N., Faggioli, A., Solazzo, F., Manco, G., Bortolani, S., Torchia, E., et al. (2025) · Journal of Neurology · doi:10.1007/s00415-025-13062-8 · Cited by 10
“Quantitative MRI-derived FF measurements correlate strongly with clinical scores and functional tests in FSHD [21] and other disorders [5].”
Metadata
- Authors
- Carlier, P. G., Marty, B., Scheidegger, O., Loureiro de Sousa, P., Baudin, P.-Y., Snezhko, E., & Vlodavets, D.
- Affiliations
- National Academy of Sciences of Belarus (BY)
- Commissariat à l'Énergie Atomique et aux Énergies Alternatives (FR)
- University of Bern (CH)
- Strasbourg University, CNRS, ICube, Strasbourg, France
- Consultants for Research in Imaging and Spectroscopy, Tournai, Belgium
- N.I. Prirogov Russian National Medical Research University, Clinical Research Institute of Pediatrics, Moscow, Russian Federation
- Corresponding author
- Carlier, Pierre G.
- Venue
- Journal of Neuromuscular Diseases
- Publisher
- SAGE Publications
- Published
- 2016-03-03
- Volume
- 3
- Issue
- 1
- Pages
- 1-28
- ISSN
- 2214-3599 (ISSN-L)
- 2214-3602
- PMC
- PMC5271435
- OpenAlex
- W2328069846
- Cited by
- 186
- References
- 292
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 21 · 2023: 21 · 2022: 16 · 2021: 25 · 2020: 34 · 2019: 25 · 2018: 8 · 2017: 7
- FWCI
- 2.06
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuromuscular Diseases (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- HAL (submittedVersion, other-oa)
- Bern Open Repository and Information System (University of Bern) (submittedVersion, cc-by-nc)
- Open Access CRIS of the University of Bern
- Topics
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Advanced MRI Techniques and Applications
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Physical Sciences › Chemistry › Spectroscopy › NMR spectroscopy and applications
- Keywords
- skeletal muscle, NMR spectroscopy, clinical trial outcome measures, neuromuscular disorders, Dixon sequence, muscle cross-sectional area, 31P NMR, muscle energetics, late gadolinium enhancement, interstitial fibrosis, diffusion NMR, texture analysis, muscle blood flow, plasma membrane integrity
- MeSH terms
- Clinical Trials as Topic, Humans, Magnetic Resonance Imaging, Neuromuscular Diseases, Outcome Assessment, Health Care, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.